Posted on Jan 21, 2005

George Butterstein, Florence B. Sherwood Professor of Life
Sciences, and George Smith,
associate professor of biology, along with Gerald Mizejewski from the New York
State Department of Health, have published a 21-page article in Cell Biology International titled
“Review and proposed action of alpha-fetoprotein growth inhibitory peptides as
estrogen and cytoskeleton-associated factors.” Human alpha-fetoprotein has been
used in the clinical laboratory as a tumor and gestational-age-dependent fetal
defect marker and in recent years has been determined to be a growth factor in
both fetal and tumor environments.